معرفی
Cherie Stabler is a Professor and Department Chair of the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida, holding the UF Foundation Preeminence Professorship. She leads the Diabetes Tissue Engineering Laboratory, focusing on biomaterials for diabetes therapy, particularly pancreatic islet transplantation. Her research integrates immunoprotection, controlled release systems, and 3D biomaterial scaffolds to enhance cellular survival and functionality.
Education: B.S. in Chemical Engineering (Florida State University, 1998); Ph.D. in Biomedical Engineering (Georgia Tech/Emory University, 2004).
Research emphasizes engineering biomaterial platforms to protect transplanted cells from immune attack, manage hypoxia, and promote vascularization. Key areas include antioxidant cerium oxide nanoparticles, oxygen-generating hydrogels, and microfluidic systems for immune response analysis.
Recent work explores modular biomaterials for localized drug delivery, 3D-printed scaffolds, and microencapsulation strategies to improve islet transplantation outcomes. Over 50 peer-reviewed articles highlight her innovation in biomaterial design and translation to clinical applications.
- Recipient of 15+ awards including BMES Fellowship, AIMBE Fellowship, and NIH grants.
- NIH Reviewer (2016-present) and leader in HIRN initiative.
- Pioneered PEGylated islet coatings for nonhuman primate models.
Labs/Teams: Directs Diabetes Tissue Engineering Lab with 10+ researchers. Collaborates with industry partners like Integra LifeSciences and NIH networks.
